ArticleFrontiers in medicine2025
Case Report: POEMS syndrome secondary to multiple solitary plasmacytomas complicated by hypertriglyceridemia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome, encompassing polyneuropathy, organomegaly, endocrinopathy, M protein (Monoclonal Immunoglobulin), and skin changes, is a rare systemic disease often marked by diverse endocrine manifestations. Diagnosis typically relies on the detection of monoclonal protein; therefore, cases lacking measurable M-protein may be easily overlooked or misdiagnosed. Case report: We describe a diagnostically challenging case involving a patient in their early fifties who presented with progressive limb numbness and weakness, skin hyperpigmentation, lower-extremity edema, hypothyroidism, and marked hypertriglyceridemia. Despite this multisystem involvement, repeated serum and bone marrow studies failed to demonstrate monoclonal protein. Subsequent imaging and pathological evaluation of the sacroiliac region revealed multiple solitary plasmacytomas with lambda light-chain restriction, which established the diagnosis of POEMS syndrome in the absence of detectable M-protein. The patient experienced notable clinical improvement following bortezomib-based chemotherapy. Conclusion: This case illustrates that POEMS syndrome should be considered even when serum and bone marrow studies do not show monoclonal protein, particularly in the presence of severe hypertriglyceridemia and multisystem injury. Awareness of such atypical presentations is essential to prevent diagnostic delay and to ensure timely initiation of appropriate therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.